These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33822472)

  • 21. Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.
    Nørgaard K; Shin J; Welsh JB; Gjessing H
    J Diabetes Sci Technol; 2015 Mar; 9(2):215-20. PubMed ID: 25591857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
    Wadwa RP; Laffel LM; Shah VN; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
    Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].
    Arranz Martín A; Calle Pascual A; Del Cañizo Gómez FJ; González Albarrán O; Lisbona Gil A; Botella Serrano M; Pallardo Sánchez LF;
    Endocrinol Nutr; 2015 Apr; 62(4):171-9. PubMed ID: 25726367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
    Tweden KS; Deiss D; Rastogi R; Addaguduru S; Kaufman FR
    Diabetes Technol Ther; 2020 May; 22(5):422-427. PubMed ID: 31697182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set.
    O'Neal DN; Adhya S; Jenkins A; Ward G; Welsh JB; Voskanyan G
    J Diabetes Sci Technol; 2013 Mar; 7(2):381-8. PubMed ID: 23566996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
    Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
    J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.
    Gu W; Liu Y; Chen Y; Deng W; Ran X; Chen L; Zhu D; Yang J; Shin J; Lee SW; Cordero TL; Mu Y
    Diabetes Metab; 2017 Sep; 43(4):359-363. PubMed ID: 28236571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do perceptions of insulin pump usability impact attitudes toward insulin pump therapy? A pilot study of individuals with type 1 and insulin-treated type 2 diabetes.
    Chamberlain JJ; Gilgen E
    J Diabetes Sci Technol; 2015 Jan; 9(1):105-10. PubMed ID: 25269659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Mobile Application Guiding Patients With Type 1 Diabetes Using Sensor-Augmented Insulin Pump Therapy.
    Esvant A; Lefebvre MA; Campillo-Gimenez B; Lannes M; Delamarre D; Guilhem I; Poirier JY
    J Diabetes Sci Technol; 2016 Jul; 10(4):985-6. PubMed ID: 26902791
    [No Abstract]   [Full Text] [Related]  

  • 36. Real-World Improvements in Hypoglycemia in an Insulin-Dependent Cohort With Diabetes Mellitus Pre/Post Tandem Basal-Iq Technology Remote Software Update.
    Pinsker JE; Leas S; Müller L; Habif S
    Endocr Pract; 2020 Jul; 26(7):714-721. PubMed ID: 33471639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
    Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
    Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue Response to Subcutaneous Infusion Catheter.
    Zhang E; Cao Z
    J Diabetes Sci Technol; 2020 Mar; 14(2):226-232. PubMed ID: 30931603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of Treating Skin Problems in Patients with Diabetes Who Use Insulin Pumps and/or Glucose Sensors.
    Berg AK; Thorsen SU; Thyssen JP; Zachariae C; Keiding H; Svensson J
    Diabetes Technol Ther; 2020 Sep; 22(9):658-665. PubMed ID: 31800294
    [No Abstract]   [Full Text] [Related]  

  • 40. An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes.
    Bode BW; Kaufman FR; Vint N
    Diabetes Technol Ther; 2017 Mar; 19(3):145-154. PubMed ID: 28135116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.